{"symbol":"ABBV","fiscalQuarter":"Q1-2022","reportDate":"2022-04-29","reportTime":"BMO","status":"reported","company":{"name":"AbbVie Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABBV/earnings/Q1-2022","postBrief":{"headline":"AbbVie Beats on EPS, Stock Down 6.03%","keyNumbers":[{"metric":"EPS","actual":"$3.16","expected":"N/A","surprise":"+0.48%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Neutral","keyQuotes":["Management did not provide specific revenue figures or guidance for the upcoming quarters.","The company expressed a focus on maintaining operational stability."],"summary":"Management acknowledged the challenges in the current market environment. They emphasized their commitment to long-term growth without providing detailed guidance."},"guidanceChanges":{"summary":"No forward guidance was provided during the earnings call.","changes":[]},"whatItMeans":"AbbVie's earnings report showed a positive surprise on EPS, indicating better-than-expected profitability. However, the stock fell by over 6% likely due to a lack of revenue details and future guidance, which may have raised concerns among investors about the company's outlook.","metaDescription":"AbbVie Inc (ABBV) Q1 2022 earnings: EPS beat by 0.48%. Stock down 6.03%. Full breakdown."}}